560 related articles for article (PubMed ID: 31900143)
1. Synthetic carbohydrate-based vaccines: challenges and opportunities.
Mettu R; Chen CY; Wu CY
J Biomed Sci; 2020 Jan; 27(1):9. PubMed ID: 31900143
[TBL] [Abstract][Full Text] [Related]
2. [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines].
Mulard L
Ann Pharm Fr; 2007 Jan; 65(1):14-32. PubMed ID: 17299349
[TBL] [Abstract][Full Text] [Related]
3. Semi- and fully synthetic carbohydrate vaccines against pathogenic bacteria: recent developments.
Zasłona ME; Downey AM; Seeberger PH; Moscovitz O
Biochem Soc Trans; 2021 Nov; 49(5):2411-2429. PubMed ID: 34495299
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Oligosaccharide Antigens for Semi-Synthetic Glycoconjugate Vaccine Leads against Streptococcus suis Serotypes 2, 3, 9 and 14*.
Zhang S; Sella M; Sianturi J; Priegue P; Shen D; Seeberger PH
Angew Chem Int Ed Engl; 2021 Jun; 60(26):14679-14692. PubMed ID: 33852172
[TBL] [Abstract][Full Text] [Related]
5. Improving vaccines against
Kaplonek P; Khan N; Reppe K; Schumann B; Emmadi M; Lisboa MP; Xu FF; Calow ADJ; Parameswarappa SG; Witzenrath M; Pereira CL; Seeberger PH
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13353-13358. PubMed ID: 30530654
[No Abstract] [Full Text] [Related]
6. An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.
Khatun F; Stephenson RJ; Toth I
Chemistry; 2017 Mar; 23(18):4233-4254. PubMed ID: 28097690
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Semi- and Fully-Synthetic Carbohydrate Vaccines Against Bacterial Infections Using a Medicinal Chemistry Approach.
Seeberger PH
Chem Rev; 2021 Apr; 121(7):3598-3626. PubMed ID: 33794090
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design.
Terra VS; Mills DC; Yates LE; Abouelhadid S; Cuccui J; Wren BW
J Med Microbiol; 2012 Jul; 61(Pt 7):919-926. PubMed ID: 22516134
[TBL] [Abstract][Full Text] [Related]
9. Glycoconjugate vaccines: current approaches towards faster vaccine design.
Micoli F; Del Bino L; Alfini R; Carboni F; Romano MR; Adamo R
Expert Rev Vaccines; 2019 Sep; 18(9):881-895. PubMed ID: 31475596
[No Abstract] [Full Text] [Related]
10. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
[TBL] [Abstract][Full Text] [Related]
11. Bacterial surface capsular polysaccharides from Streptococcus pneumoniae: A systematic review on structures, syntheses, and glycoconjugate vaccines.
Javed ; Mandal PK
Carbohydr Res; 2021 Apr; 502():108277. PubMed ID: 33743443
[TBL] [Abstract][Full Text] [Related]
12. Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.
Adamo R
Acc Chem Res; 2017 May; 50(5):1270-1279. PubMed ID: 28463499
[TBL] [Abstract][Full Text] [Related]
13. Glycoconjugate vaccines: some observations on carrier and production methods.
MacCalman TE; Phillips-Jones MK; Harding SE
Biotechnol Genet Eng Rev; 2019 Oct; 35(2):93-125. PubMed ID: 32048549
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate-based synthetic vaccines: does the synthesis of longer chains of carbohydrates make this a step ever closer?
Chu KC; Wu CY
Future Med Chem; 2012 Sep; 4(14):1767-70. PubMed ID: 23043471
[No Abstract] [Full Text] [Related]
15. Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production.
Dow JM; Mauri M; Scott TA; Wren BW
Expert Rev Vaccines; 2020 Jun; 19(6):507-527. PubMed ID: 32627609
[TBL] [Abstract][Full Text] [Related]
16. Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
Goyette-Desjardins G; Calzas C; Shiao TC; Neubauer A; Kempker J; Roy R; Gottschalk M; Segura M
Infect Immun; 2016 Jul; 84(7):2059-2075. PubMed ID: 27113360
[TBL] [Abstract][Full Text] [Related]
17. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs.
Berti F; Micoli F
Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591
[TBL] [Abstract][Full Text] [Related]
18. Spectroscopic studies of the structure and stability of glycoconjugate vaccines.
Jones C; Lemercinier X; Crane DT; Gee CK; Austin S
Dev Biol (Basel); 2000; 103():121-36. PubMed ID: 11214231
[No Abstract] [Full Text] [Related]
19. Capsular polysaccharide and conjugate vaccines.
Mäkelä PH
Zentralbl Bakteriol; 1994 Oct; 281(3):334-9. PubMed ID: 7696754
[No Abstract] [Full Text] [Related]
20. A semisynthetic
Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
